Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Montelukast and Gabapentin for pruritus in hemodialysis patients
IRCT20180617040114N3Phase 3Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of montelukast and gabapentin in pruritus and end-stage kidney disease (ESKD), sponsored by Arak University of Medical Sciences. Started Jun 2020; status: completed.
02
Drugs
montelukastgabapentin
03
Conditions
pruritusend-stage kidney disease (ESKD)
Beyond the preview
Go deeper on IRCT20180617040114N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180617040114N3.